New Enterprise Associates Inc. is likely to open a Boston office within the next half a year, General Partner David Mott told the Boston Business Journal.
The fact that it's Mott - former MedImmune chief and a prominent life sciences investor - saying this suggests the move is all about biotech. His comments to the Boston paper back up this notion: “Boston is winning the biopharma innovation race, versus other geographies." Mott is based in Maryland.